| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 79 | 14.480 | 81.494 | 160.455 | 183.954 | 171.863 | 254.182 | 273.151 | 284.151 | 280.536 |
| Total Income - EUR | 79 | 14.480 | 81.494 | 160.455 | 185.561 | 171.980 | 310.788 | 279.904 | 321.831 | 284.708 |
| Total Expenses - EUR | 33 | 13.244 | 51.811 | 110.714 | 142.585 | 140.737 | 255.808 | 245.735 | 288.662 | 258.453 |
| Gross Profit/Loss - EUR | 46 | 1.236 | 29.683 | 49.741 | 42.976 | 31.244 | 54.980 | 34.170 | 33.169 | 26.256 |
| Net Profit/Loss - EUR | 40 | 999 | 28.787 | 48.216 | 41.120 | 29.624 | 51.848 | 31.451 | 30.358 | 22.531 |
| Employees | 0 | 0 | 0 | 3 | 3 | 2 | 4 | 5 | 5 | 2 |
Check the financial reports for the company - Caroll Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 46 | 1.173 | 17.859 | 79.044 | 81.606 | 115.686 | 75.992 | 114.481 | 131.047 | 142.922 |
| Current Assets | 77 | 2.260 | 41.039 | 1.516 | 20.481 | 38.513 | 32.431 | 48.726 | 34.015 | 42.897 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 122 | 0 | 124 | 366 | 364 |
| Receivables | 0 | 1.880 | 12.848 | 54 | 5.602 | 1.149 | 9.915 | 6.593 | 23.678 | 24.515 |
| Cash | 77 | 380 | 28.191 | 1.462 | 14.879 | 37.242 | 22.516 | 42.009 | 9.971 | 18.018 |
| Shareholders Funds | 105 | 1.103 | 29.872 | 29.511 | 70.060 | 84.947 | 81.693 | 113.397 | 126.930 | 136.515 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 62 | 61 | 61 | 61 | 60 |
| Debts | 18 | 2.329 | 29.146 | 51.167 | 32.143 | 69.366 | 26.842 | 49.810 | 38.131 | 49.305 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Caroll Med Srl